Antinociceptive profile of ring A-reduced progesterone metabolites in the formalin test

Pain

Volumn 138, Issue 2, 2008, Pages 402-409

  Ocvirk, Rok ^a   Pearson Murphy, Beverley E ^a,b   Franklin, Keith B J ^a   Abbott, Frances V ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Dihydroprogesterone; Formalin test; GABA; Pain; Pregnanolone; Tetrahydroprogesterone

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3BETA HYDROXY 5BETA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 5ALPHA PREGNANE 3,20 DIONE; 5BETA DIHYDROPROGESTERONE; BICUCULLINE; ELTANOLONE; FORMALDEHYDE; INDOMETACIN; ISOPREGNANOLONE; PROGESTERONE; PROGESTERONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; METABOLITE; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYDROGESTERONE; MALE; PAIN MEASUREMENT; PREGNANOLONE; PROGESTERONE; RATS; RATS, LONG-EVANS;

EID: 49049094202     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.01.019     Document Type: Article

References (43)

1. Abbott F.V., and Hellemans K.G. Phenacetin, acetaminophen and dipyrone: analgesic and rewarding effects. Behav Brain Res 112 (2000) 177-186
2. Abbott F.V., Ocvirk R., Najafee R., and Franklin K.B.J. Improving the efficiency of the formalin test. Pain 83 (1999) 561-569
3. Bair M.J., Robinson R.L., Katon W., and Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 163 (2003) 2433-2445
4. Belelli D., Lan N.C., and Gee K.W. Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex. Neurosci Biobehav Rev 14 (1990) 315-322
5. Callachan H., Cottrell G.A., Hather N.Y., Lambert J.J., Nooney J.M., and Peters J.A. Modulation of the GABAA receptor by progesterone metabolites. Proc R Soc Lond B Biol Sci 231 (1987) 359-369
6. Carlsson K.H., and Jurna I. Interaction of pentobarbital and morphine in the tail-flick test performed on rats: synergism at the spinal and antagonism at the supraspinal level. Neurosci Lett 71 (1986) 356-360
7. Dubuisson D., and Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4 (1977) 161-174
8. Fishbain D.A., Cutler R., Rosomoff H.L., and Rosomoff R.S. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 13 (1997) 116-137
9. Frye C.A., and Duncan J.E. Progesterone metabolites, effective at the GABAA receptor complex, attenuate pain sensitivity in rats. Brain Res 643 (1994) 194-203
10. Gee K.W., McCauley L.D., and Lan N.C. A putative receptor for neurosteroids on the GABAA receptor complex: the pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol 9 (1995) 207-227
11. Genazzani A.R., Monteleone P., Stomati M., Bernardi F., Cobellis L., Casarosa E., et al. Clinical implications of circulating neurosteroids. Int Rev Neurobiol 46 (2001) 399-419
12. Gilbert A.K., and Franklin K.B. GABAergic modulation of descending inhibitory systems from the rostral ventromedial medulla (RVM). Dose-response analysis of nociception and neurological deficits. Pain 90 (2001) 25-36
13. Gyermek L. Effects of pregnanolone and progesterone. Lancet 2 (1968) 1195
14. Gyermek L., Iriarte J., and Crabbe P. Steroids. CCCX. Structure-activity relationship of some steroidal hypnotic agents. J Med Chem 11 (1968) 117-125
15. Jasmin L., Wu M.V., and Ohara P.T. GABA puts a stop to pain. Curr Drug Targets CNS Neurol Disord 3 (2004) 487-505
16. Kavaliers M., and Wiebe J.P. Analgesic effects of the progesterone metabolite, 3 alpha-hydroxy-5 alpha-pregnan-20-one, and possible modes of action in mice. Brain Res 415 (1987) 393-398
17. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
18. Mellon S.H., Griffin L.D., and Compagnone N.A. Biosynthesis and action of neurosteroids. Brain Res Brain Res Rev 37 (2001) 3-12
19. Mellon S.H., and Vaudry H. Biosynthesis of neurosteroids and regulation of their synthesis. Int Rev Neurobiol 46 (2001) 33-78
20. Mok W.M., Herschkowitz S., and Krieger N.R. Evidence that 3 alpha-hydroxy-5 alpha-pregnan-20-one is the metabolite responsible for anesthesia induced by 5 alpha-pregnanedione in the mouse. Neurosci Lett 135 (1992) 145-148
21. Mok W.M., and Krieger N.R. Evidence that 5 alpha-pregnan-3 alpha-ol-20-one is the metabolite responsible for progesterone anesthesia. Brain Res 533 (1990) 42-45
22. Monteleone P., Luisi S., Tonetti A., Bernardi F., Genazzani A.D., Luisi M., et al. Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 142 (2000) 269-273
23. Mosteller F., and Tukey J. Data analysis, including statistics. In: Lindsay G., and Aronson E. (Eds). Handbook of social psychology (1968), Addison-Wesley, Reading, MA 80-203
24. Murphy B.E.P., Abbott F.V., Allison C.M., Watts C., and Ghadirian A.M. Elevated levels of some neuroactive progesterone metabolites, particularly isopregnanolone, in women with chronic fatigue syndrome. Psychoneuroendocrinology 29 (2004) 245-268
25. Nijs J., Van de Velde B., and De Meirleir K. Pain in patients with chronic fatigue syndrome: does nitric oxide trigger central sensitisation?. Med Hypotheses 64 (2005) 558-562
26. Ossipov M.H., and Gebhart G.F. Light pentobarbital anesthesia diminishes the antinociceptive potency of morphine administered intracranially but not intrathecally in the rat. Eur J Pharmacol 97 (1984) 137-140
27. Pardridge W.M., and Mietus L.J. Regional blood-brain barrier transport of the steroid hormones. J Neurochem 33 (1979) 579-581
28. Pathirathna S., Todorovic S.M., Covey D.F., and Jevtovic-Todorovic V. 5alpha-reduced neuroactive steroids alleviate thermal and mechanical hyperalgesia in rats with neuropathic pain. Pain 117 (2005) 326-339
29. Paul S.M., and Purdy R.H. Neuroactive steroids. FASEB J 6 (1992) 2311-2322
30. Pearson Murphy B.E., and Allison C.M. Determination of progesterone and some of its neuroactive ring A-reduced metabolites in human serum. J Steroid Biochem Mol Biol 74 (2000) 137-142
31. Pirog E.C., and Collins D.C. 3 alpha-hydroxysteroid dehydrogenase activity in rat liver and skin. Steroids 59 (1994) 259-264
32. Rapkin A.J., Morgan M., Goldman L., Brann D.W., Simone D., and Mahesh V.B. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90 (1997) 709-714
33. Romeo E., Strohle A., Spalletta G., di Michele F., Hermann B., Holsboer F., et al. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155 (1998) 910-913
34. Roychowdhury S.M., and Fields H.L. Endogenous opioids acting at a medullary mu-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray. Neuroscience 74 (1996) 863-872
35. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 91 (1994) 12013-12017
36. Selye H. Correlations between the chemical structures and the pharmacological actions of the steroids. Endocrinology 30 (1942) 437-453
37. Shibata M., Ohkubo T., Takahashi H., and Inoki R. Modified formalin test: characteristic biphasic pain response. Pain 38 (1989) 347-352
38. Smithgall T.E., and Penning T.M. Indomethacin-sensitive 3 alpha-hydroxysteroid dehydrogenase in rat tissues. Biochem Pharmacol 34 (1985) 831-835
39. Ströhle A., Romeo E., Hermann B., Pasini A., Spalletta G., di Michele F., et al. Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry 45 (1999) 274-277
40. Tjølsen A., Berge O.G., Hunskaar S., Rosland J.H., and Hole K. The formalin test: an evaluation of the method. Pain 51 (1992) 5-17
41. Trauger J.W., Jiang A., Stearns B.A., and LoGrasso P.V. Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2). Biochemistry (Moscow) 41 (2002) 13451-13459
42. van Broekhoven F., and Verkes R.J. Neurosteroids in depression: a review. Psychopharmacology (Berl) 165 (2003) 97-110
43. Winfree C.J., Coombs D.W., DeLeo J.A., and Colburn R.W. Analgesic effects of intrathecally-administered 3 alpha-hydroxy-5 alpha-pregnan-20-one in a rat mechanical visceral pain model. Life Sci 50 (1992) 1007-1012